C-Bond Systems’ Intellectual Property Portfolio Valued at $33.7 Million by Leading Global IP Valuation Firm

The intellectual property valuation encompassed a review and assessment of the Company’s patented nanotechnologies including C-Bond NanoShield™, a windshield strengthening solution, C-Bond BRS, a ballistic resistant film system, and the C-Bond I window film mounting solution. The valuation also included an assessment of the Company’s developed technology for future applications including solar panels, bottling, and consumer electronics.

C-Bond NanoShield™, available with and without a hydrophobic (water repellent), is a glass strengthening liquid that reduces windshield chipping and cracking. The product is sprayed directly onto a windshield and then wiped off using a squeegee. C-Bond NanoShield's unique technology repairs the microscopic flaws and defects that weaken the glass composite structure and ultimately act as failure initiators. The strengthening process begins immediately upon application.

C-Bond BRS consists of the patented C-Bond glass strengthening technology, which increases glass strength and flexibility by chemically bonding to the defects randomly distributed on the glass surface to help prevent breakage, and a private-label security film.  C-Bond BRS is validated to provide NIJ Level I, Level IIA, Level II, and UL 752 ballistic-resistant protection by an independent third-party laboratory.  

C-Bond I enhances window film installation and overall quality by improving the adhesion of the window film to the glass to which it is applied and eliminating defects such as fogging. C-Bond I can be used with any film manufacturer’s product.

“C-Bond’s robust and unique intellectual property portfolio is what drew me to the Company almost two years ago,” stated Scott R. Silverman, Chairman and CEO of C-Bond. “This valuation validates our technology platform and the numerous opportunities our intellectual property can address. Bolstered with this new information, we believe we will have stronger opportunities to collaborate with strategic partners and investors.”

C-Bond has filed, licensed and/or acquired a total of 22 individual patents and patent applications spanning core and strategic nanotechnology applications and processes.